Interview with Dr Peter A Kaufman

Dr Peter A Kaufman, discussed the promising activity demonstrated by motesanib in a small phase 1b trial of women with locally recurrent, unresectable, or metastatic breast cancer.

Dr Peter A Kaufman, Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, discussed the promising activity demonstrated by motesanib in a small phase 1b trial of women with locally recurrent, unresectable, or metastatic breast cancer.

MP3 DOWNLOAD: PETER_KAUFMAN.mp3

(Right click to download podcast)